Clinical trial

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)

NCT06193239

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-10-05

PhasePHASE2

Study timeline

Study start (actual)2023-10-05Date precision: day

Registry last updated2026-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

OWL-EVO1DIAGNOSTIC_TEST

Sponsors & collaborators

Owlstone Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06193239 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.